Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
- Conditions
- Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
- Registration Number
- NCT04220970
- Lead Sponsor
- The Lymphoma Academic Research Organisation
- Brief Summary
Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant.
Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP).
This registry is opened in France and in Belgium
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 150
- Adult patients with an anaplastic large cell lymphoma associated with breast implants
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall response 13 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (31)
A. Z. Sint-Jan Brugge-Oostende AV
🇧🇪Bruges, Belgium
Clinique Universitaire Saint LUC
🇧🇪Brussels, Belgium
Institut Jules Bordet
🇧🇪Brussels, Belgium
Universitair Ziekenhuis Brussel
🇧🇪Brussel, Belgium
Cliniques Universitaires de Bruxelles - Hôpital Erasme
🇧🇪Bruxelles, Belgium
Universitair Ziekenhuis Antwerpen
🇧🇪Edegem, Belgium
Universitair Ziekenhuis Gent
🇧🇪Gent, Belgium
U.Z. Leuven - Campus Gasthuisberg
🇧🇪Leuven, Belgium
CHU de Liège -Domaine Sart Tilman
🇧🇪Liège, Belgium
CHU UCL Namur - Site Godinne
🇧🇪Yvoir, Belgium
Scroll for more (21 remaining)A. Z. Sint-Jan Brugge-Oostende AV🇧🇪Bruges, BelgiumSylvia SNAUWAERT, MDContact+32 (0)50 45 23 28sylvia.snauwaert@azsintjan.be